Kidney News and Research

RSS

Mursla Bio publishes peer-reviewed validation of tissue-specific extracellular vesicle platform for liquid biopsy

Mursla Bio, a precision medicine and diagnostics company built on tissue-specific extracellular vesicles (TS-EVs), today announced publication of a peer-reviewed study in the Journal of Extracellular Vesicles (impact factor 21.7), the founding journal of the International Society for Extracellular Vesicles. This validates the TS-EV platform for a new class of liquid biopsy: the multiomic disease biology of living cells in a chosen tissue, read from blood, starting with the liver.

From Mursla Bio 13 Oct 2026

Targeting lipophagy could help treat metabolic and oxidative stress-related diseases

A review published in Genes & Diseases highlights lipophagy, the cellular process that selectively breaks down lipid droplets, as a potentially important therapeutic target for conditions driven by disrupted lipid metabolism and oxidative stress.

12 Oct 2026

Proposed heart transplant policy uses objective data to save lives

Donor organs are exceedingly scarce, so much so that one in five people on the waiting list for a heart transplant in the U.S. dies or is removed from the list before receiving a transplant.

12 Oct 2026

Researchers followed glucose monitor users for three years and found a possible kidney benefit

A study of more than 25,000 analytical group assignments involving high-risk adults with type 2 diabetes found that sustained real-time continuous glucose monitoring (rtCGM) was associated with substantial improvements in blood sugar control over three years. Continued use was also linked to lower levels of a marker of kidney damage after three years, although researchers found no evidence that the technology preserved kidney filtration function.

12 Oct 2026

Better blood pressure control could prevent over 518,000 annual deaths worldwide

Effective management of high blood pressure could prevent more than 518,000 annual deaths from cardiovascular disease around the world, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2026.

11 Oct 2026

Cutting sugary drinks helps reduce childhood obesity, study finds

While the adult obesity rate appears to be slowing in the United States, childhood obesity remains historically high, affecting nearly 1 in 5 school-aged children.

9 Oct 2026

Masked high blood pressure linked to higher risk of falls in older adults

Masked high blood pressure in adults older than age 78 is associated with a 70% higher risk of falls compared to high blood pressure readings in the office and at home among peers, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2026.

9 Oct 2026

Body fat distribution may influence hunger hormones more than daily diet

Body fat distribution may reveal more about hunger hormones than recent diet.

9 Oct 2026

US counties with more medical debt see higher rates of several late-stage cancers

Higher medical debt is linked to more late-stage cancer diagnoses across U.S. counties.

9 Oct 2026

New iron deficiency guidelines raise key blood test cutoffs

ASH 2026 guidelines redefine iron deficiency diagnosis with higher ferritin thresholds, aiming for better detection and management across diverse populations.

9 Oct 2026

Longer sleep duration linked to diabetic kidney disease risk

People with type 2 diabetes who sleep longer may have an increased risk of developing or worsening existing diabetic kidney disease, according to a study published in the Journal of the Endocrine Society.

8 Oct 2026

Potassium-rich DASH diet does not cause hyperkalemia in individuals taking blood pressure drugs

Increased consumption of potassium-rich foods that are part of the Dietary Approaches to Stop Hypertension (DASH) diet did not raise blood potassium to dangerous levels in people taking medications to lower their blood pressure, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2026.

8 Oct 2026

Combination therapy overcomes immunotherapy resistance in glioblastoma

Scientists at The Wistar Institute have identified a combination treatment that overcomes two of the biggest barriers to immunotherapy in glioblastoma.

8 Oct 2026

A New Approach to Preventing Bladder Cancer Recurrence

Innovative techniques using electrical energy to treat bladder cancer may lower recurrence rates and minimize the need for radical surgical interventions.

8 Oct 2026

Three NHS genetics labs fail to routinely share vital variant data

Three out of England's seven NHS genetics laboratories are failing to routinely share vital information about genetic variants in public databases that helps patients with rare diseases access diagnosis and care, reveals an investigation by The BMJ today.

8 Oct 2026

High expression of CTDNEP1 gene linked to poorer kidney cancer survival

Renal cell carcinoma (RCC) is the most common form of kidney cancer, accounting for about 90% of kidney cancers.

7 Oct 2026

Does extra protein protect aging muscle during fasting?

A randomized trial found that alternate-day fasting reduced weight in older men, while added protein and leucine did not prevent lean mass loss.

7 Oct 2026

Study links pregnancy complications to future heart and kidney disease

Women with a complication in the latest pregnancy, or in a previous pregnancy, face an elevated risk of developing cardiometabolic-renal conditions in subsequent years, suggests a UK study published online in the open access journal BMJ Medicine.

6 Oct 2026

UCLA scientist develops new way to map cellular metabolism

Nutrition advice is everywhere. Eat more protein. Cut back on sugar. Get more fiber. But beneath all that advice is a surprisingly basic gap in our understanding: Scientists still have a limited view of what happens when specific nutrients reach individual cells inside the body.

6 Oct 2026

SGLT2 inhibitors reduce inflammatory cells linked to heart disease

For the first time in a human trial, a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, already known for their weight loss and glucose lowering benefits, has been shown to also reduce inflammatory cells in the blood known to cause cardiovascular disease.

6 Oct 2026